<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Metab (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Metab (Lond)</journal-id><journal-title-group><journal-title>Nutrition &#x00026; Metabolism</journal-title></journal-title-group><issn pub-type="epub">1743-7075</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23442518</article-id><article-id pub-id-type="pmc">3599636</article-id><article-id pub-id-type="publisher-id">1743-7075-10-24</article-id><article-id pub-id-type="doi">10.1186/1743-7075-10-24</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title><italic>Kochujang</italic>, fermented soybean-based red pepper paste, decreases visceral fat and improves blood lipid profiles in overweight adults</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Cha</surname><given-names>Youn-Soo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cha8@jbnu.ac.kr</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Kim</surname><given-names>Soo-Ran</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>trisr1114@nate.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Yang</surname><given-names>Ji-Ae</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>jiya00@nate.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Back</surname><given-names>Hyang-Im</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>back-hyang@hanmail.net</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Kim</surname><given-names>Min-Gul</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mgkim@jbctc.org</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Jung</surname><given-names>Su-Jin</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>sjjeong@jbctc.org</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Song</surname><given-names>Won O</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>song@anr.msu.edu</email></contrib><contrib contrib-type="author" corresp="yes" id="A8"><name><surname>Chae</surname><given-names>Soo-Wan</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>soowan@jbnu.ac.kr</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Food Science and Human Nutrition, Chonbuk National University, Obesity Research Center, 664-14 Dukjin-Dong 1-Ga, Jeonju, Jeonbuk, 561-756, Republic of Korea</aff><aff id="I2"><label>2</label>Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, 634-18, Geumam-dong, Deokjin-gu, Jeonju, Jeonbuk, 561-172, Republic of Korea</aff><aff id="I3"><label>3</label>Department of Pharmacology, Chonbuk National University, Medical School, Jeonju, Jeonbuk, 561-172, Republic of Korea</aff><aff id="I4"><label>4</label>Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI, 48824-1224, USA</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>26</day><month>2</month><year>2013</year></pub-date><volume>10</volume><fpage>24</fpage><lpage>24</lpage><history><date date-type="received"><day>5</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2013 Cha et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Cha et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.nutritionandmetabolism.com/content/10/1/24"/><abstract><sec><title>Abstract</title><p>Health benefits of <italic>Kochujang</italic> (KCJ) and its bioactive compounds have been reported in several in vitro and animal studies.</p></sec><sec><title>Objective</title><p>The aim of this study was to investigate the efficacy of KCJ supplementation on body composition and blood lipid profiles in overweight adults.</p></sec><sec><title>Methods</title><p>Sixty overweight men and women with BMI &#x02265;23 kg/m<sup>2</sup> and waist-hip-ratio (WHR) &#x02265;0.90 for men and &#x02265;0.85 for women were randomly assigned to a KCJ supplement (n=30, 32 g/day) or placebo (n=30, 32 g/day) group for a 12-week, double-blind, placebo controlled study. We measured anthropometric parameters, serum lipid profiles, abdominal fat distribution by computerized tomography and calculated the atherosclerosis indices in 53 subjects (n=26 in <italic>KCJ</italic> group, n=27 in placebo group) who completed the study.</p></sec><sec><title>Results</title><p>After 12 weeks, the KCJ group showed a significant reduction in visceral fat (cm<sup>2</sup>) (<italic>p</italic>&#x0003c;0.05), although body weight (kg) and WHR did not change. Serum concentration of triglycerides and ApoB were decreased when compared to those of the placebo group.</p></sec><sec><title>Conclusion</title><p>KCJ supplementation (32 g/day) for 12 weeks in overweight adults showed anti-atherosclerotic and anti-obesogenic effects.</p></sec><sec><title>Trial registration</title><p>Clinical trials.gov Identifier:
<ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01532375">NCT01532375</ext-link></p></sec></abstract><kwd-group><kwd><italic>Kochujang</italic> (KCJ)</kwd><kwd>Visceral fat</kwd><kwd>Triglyceride</kwd><kwd>Atherosclerosis index</kwd><kwd>Apolipoprotein</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>The increasing westernized Korean dietary lifestyle, including frequently eating away from home, has favored foods that have not been a part of the traditional Korean diet
[<xref ref-type="bibr" rid="B1">1</xref>]. The changing consumers&#x02019; demand for western food products and diminished traditional dietary lifestyle have overlapped with the prevalence of obesity and obesity-related chronic diseases in Korea
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. <italic>Kochujang</italic> (KCJ), a fermented soybean-based red pepper paste, has long been one of the most representative and commonly used seasonings in Korean cuisine as a sauce, dressing or seasoning for meat, vegetable dishes, stew and soup. The KCJ is produced by fermenting powder red peppers combined with powdered meju (fermented soybean powder), salt, malt-digested rice syrup, and rice flour for about six months. The fermentation process extends the storage period while increasing bioavailability of bioactive ingredients
[<xref ref-type="bibr" rid="B4">4</xref>] such as free amino acids, peptides, alcohols, organic acids, capsaicin and flavonoids
[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. KCJ has unique flavors of sweet and hot red pepper combined with savory soybean protein hydrolyzate and nucleic acids. In recent years, KCJ has gained its popularity outside Korea for its taste and health benefits derived from the several ingredients
[<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B16">16</xref>] that are produced by the fermentation process
[<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. The functional substances either singularly or in combinations have exhibited anti-obesogenic, anti-oxidative, and anti-mutagenic properties in several <italic>in vitro</italic> experiments and in various murine models
[<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. Anti-obesogenic and anti-atherogenic properties of fermented soy products have been demonstrated in obese adults
[<xref ref-type="bibr" rid="B23">23</xref>], possibly through modulation of hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, and acyl-CoA oxidase
[<xref ref-type="bibr" rid="B24">24</xref>]. Recently Ludy and Mattes
[<xref ref-type="bibr" rid="B25">25</xref>] reported that hedonically acceptable doses of red pepper altered thermogenesis and appetite. Their findings are consistent with previous reports of Reinbach et al
[<xref ref-type="bibr" rid="B26">26</xref>] and others
[<xref ref-type="bibr" rid="B27">27</xref>] who reported the alteration of appetite and energy balance as a result of red pepper or capsaicin intake. Lee et al
[<xref ref-type="bibr" rid="B28">28</xref>] suggested that the alterations could be through changes in orexigenic and anorexigenic neuropeptides in hypothalamus.</p><p>With the epidemic of obesity and diabetes growing around the world, KCJ could be potentially effective in preventing and treating obesity and cardiovascular risks
[<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B20">20</xref>] if proven in humans. To date however no clinical trials of human feeding studies have been reported with KCJ supplementation. In the present randomized, double-blind, placebo-controlled clinical trial, we tested the hypothesis that KCJ supplementation decreases body fat and improves blood lipid profiles in overweight adults.</p></sec><sec sec-type="methods"><title>Subjects and methods</title><sec><title>Study subjects</title><p>Healthy men and women volunteers, 19 to 65 years of age, with BMI &#x02265;23&#x02009;kg/m<sup>2</sup> and WHR of &#x0003e; 0.90 for men and &#x0003e;0.85 for women participated in the study. Excluded from the study were individuals with (1) lipid metabolic disorders; (2) &#x0003e;10% changes in body weight in the past 3 months; (3) cardiovascular disease such as arrhythmia, heart failure, myocardial infarction, and wearing pacemaker; (4) allergy or hypersensitivity to any of the ingredients in the test products; (5) history of reaction to any of the experimental products or of gastrointestinal diseases such as Crohn&#x02019;s disease or gastrointestinal surgery (caecum or enterocele surgery); (6) participation in other clinical trials within the past 2 months; (7) abnormal hepatic liver function, renal disease such as acute/chronic renal failure, nephrotic syndrome; (8) use of anti-psychosis drug therapy within 2 months; (9) laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study; (10) history of alcohol or substance abuse; and (11) pregnancy or breastfeeding. All subjects willfully signed consent to participate in the study after receiving a detailed explanation of the purpose with research procedures. The research protocol was approved by the Institutional Review Board of Chonbuk National University Hospital's <italic>Clinical Trial Center for Functional Food</italic>.</p></sec><sec><title>Study design</title><p>At the onset of the study, each subject was interviewed for demographic information such as sex, date of birth, age and other lifestyle factors such as past smoking, drinking and medical histories. The subjects were divided into a KCJ group (n=30) and a placebo group (n=30) for the 12-week randomized, double-blind, placebo-controlled design. The KCJ supplement (32 g/day in pills) was equivalent to the usual daily intake of 39g wet weight of KCJ as consumed by Koreans. The KCJ used in the study was produced by the standardized manufacturing process and ingredients. Then a single batch KCJ was lyophilized and made into pills for the entire study (Imshil Herbal Medicine Co, Imsil, Republic of Korea). The placebo supplement had the same appearance and caloric contents without the principal ingredients that are present in KCJ (Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p><bold>Composition of </bold><bold><italic>Kochujang </italic></bold><bold>and placebo supplements (g/day)</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left">&#x000a0;</th><th align="left"><bold>Kochujang</bold></th><th align="left"><bold>Placebo</bold></th></tr></thead><tbody><tr><td align="left" valign="bottom">Glutinous rice flour (g)<hr/></td><td align="left" valign="bottom">10.9<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">Powdered red pepper(g)<hr/></td><td align="left" valign="bottom">11.9<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">Malt (g)<hr/></td><td align="left" valign="bottom">5.2<hr/></td><td align="left" valign="bottom">-<hr/></td></tr><tr><td align="left" valign="bottom">Powdered fermented soybeans (g)<hr/></td><td align="left" valign="bottom">4.7<hr/></td><td align="left" valign="bottom">1.1<hr/></td></tr><tr><td align="left" valign="bottom">Spicy flavor powder(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">0.1<hr/></td></tr><tr><td align="left" valign="bottom">Perfume of red pepper(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">0.3<hr/></td></tr><tr><td align="left" valign="bottom">Honey(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">1.4<hr/></td></tr><tr><td align="left" valign="bottom">Caramel pigment(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">0.1<hr/></td></tr><tr><td align="left" valign="bottom">Salt (g)<hr/></td><td align="left" valign="bottom">5.2<hr/></td><td align="left" valign="bottom">1.4<hr/></td></tr><tr><td align="left" valign="bottom">Soy sauce (g)<hr/></td><td align="left" valign="bottom">2.1<hr/></td><td align="left" valign="bottom">6.7<hr/></td></tr><tr><td align="left" valign="bottom">Powdered cowpeas (g)<hr/></td><td align="left" valign="bottom">7.5<hr/></td><td align="left" valign="bottom">9.3<hr/></td></tr><tr><td align="left" valign="bottom">Powdered cocoa (g)<hr/></td><td align="left" valign="bottom">2.5<hr/></td><td align="left" valign="bottom">1.4<hr/></td></tr><tr><td align="left" valign="bottom">Powdered vegetable fat(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">6.3<hr/></td></tr><tr><td align="left" valign="bottom">Wheat flour(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">13.1<hr/></td></tr><tr><td align="left" valign="bottom">Red colors(g)<hr/></td><td align="left" valign="bottom">-<hr/></td><td align="left" valign="bottom">1.5<hr/></td></tr><tr><td align="left" valign="bottom">Total wet weight (g)<hr/></td><td align="left" valign="bottom">50<hr/></td><td align="left" valign="bottom">43<hr/></td></tr><tr><td align="left" valign="bottom">Freeze-dried weight (g)<hr/></td><td align="left" valign="bottom">32<hr/></td><td align="left" valign="bottom">32<hr/></td></tr><tr><td align="left">Energy (kcal)</td><td align="left">114</td><td align="left">113.1</td></tr></tbody></table></table-wrap><p>The subjects were instructed to maintain their usual lifestyle and activity levels and avoid other functional foods or dietary supplements during the 12-week study period. The subjects visited the clinic every 4 weeks for a total of five clinic visits (initial screening, and at weeks 0, 4, 8, 12) for monitoring and assessment of compliance with the protocol. At both the beginning and at the end of the 12-week intervention; anthropometric and biochemical parameters, computed tomography, vital signs, and dietary intakes were measured for both KCJ and placebo groups. At each visit to the clinic, the subjects were asked about adverse effects experienced, changes in physical activity, lifestyle, eating patterns, and pill compliance.</p></sec><sec><title>Anthropometric measurements</title><p>Height was measured using a DS-102 (JENIX, Korea). Weight, BMI, % body fat, body fat mass, muscle mass, and WHR were measured using bioelectrical impedance analysis (Inbody 3.0, Biospace Co., Seoul, Korea). At weeks 0 and 12, visceral fat, subcutaneous fat, and total fat were also measured using computed tomography (CT) scans and visceral to subcutaneous ratios (VSR) were calculated. Having lumbar vertebrae 4 (L4) as the center, five different regions between -20 and +20 were photographed for the abdominal fat area calculation. Visceral fat and subcutaneous fat were divided after setting the boundary between the abdominis and the peritoneum. After computing the numeric value of the total fat and visceral fat area, the subcutaneous fat area was calculated by subtracting the area of visceral fat from the total fat. The proportion was calculated as VSR.</p></sec><sec><title>Serum lipid, lipoprotein, atherosclerosis and index in glycaemic control factor</title><p>Fasted blood samples (&#x0003e;12 hr) were used to assess the blood lipid profiles: total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), free fatty acid (FFA), apolipoprotein AI (ApoA<sub>1</sub>), apolipoprotein B (ApoB), fasting plasma glucose, and HbA1c. Blood tests were conducted with a Hitachi 7600-110 analyzer (Hitachi High-Technologies Corp., Tokyo, Japan) by standard methods
[<xref ref-type="bibr" rid="B23">23</xref>] used in the clinical laboratory of <italic>Chonbuk National University Hospital</italic>. Atherosclerosis Indices (AI) were measured by calculating the ratios (TC-HDL)/HDL, LDL/HDL and ApoB/ApoA1. The Cardiac Index (CI) was also calculated by the TC/HDL ratio.</p></sec><sec><title>Safety and dietary assessment</title><p><bold>Safety measurements</bold> for the subjects were taken by electrocardiogram, hematology test and blood chemistry tests, i.e., white blood and red blood cell counts, hemoglobin, hematocrit, platelet count, total protein, albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine levels
[<xref ref-type="bibr" rid="B29">29</xref>]. Pulse and blood pressure were measured at each visit after a 10-minute rest, using the OMRONT4 digital blood pressure monitor (OMRON Corp., Tokyo, Japan). Each subject completed a 3-day dietary record for two weekdays and one weekend day in order to evaluate the energy intake and diet quality at each clinic visit. The twenty-four hour dietary intake data were analyzed by one dietitian throughout the study using Can-Pro 3.0 software (The Korean Nutrition Society, Seoul, Republic of Korea).</p></sec><sec><title>Statistical analysis</title><p>Statistical analyses were performed using SAS version 9.0 for Windows (SAS Institute, Cary, NC, USA) and SPSS for Windows, version 16.0 (SPSS, Chicago, USA). Data were expressed as the mean and standard errors (SE).</p><p>The statical analysis for the main analysis were performed according to the intention-to &#x02013;treat principle. Sample size for the study was based on the mean (SE) cm<sup>2</sup> of visceral fat difference between treatments in the previous study
[<xref ref-type="bibr" rid="B30">30</xref>], -7.8 (3.6) cm<sup>2</sup> for the experimental group and +3.9 (6.4) cm<sup>2</sup> for the placebo group. It was estimated to provide 80% power to detect a difference between groups in visceral fat of 11.7(SD; 20.5) cm<sup>2</sup> with &#x003b1; = .05, using a 2-tailed <italic>t</italic>-test of the difference between means. The minimum sample size was determined to 48 participants (24 per group) by calculated, to allow for a 20% dropout rate a total of 60 participants were selected.</p><p>Between subjects t-tests were calculated for all variables measures to determine whether there were changes associated with the treatment group. Within each treatment group, paired comparison t tests were calculated to test whether the change from 0-week to 12-week. Repeated measures mixed model analysis of variance was performed to see whether there were effects associated with time (with-person variable), treatment group (between&#x02013;group variable), or the interaction of time and treatment group.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Study subjects</title><p>The sampling and trial profiles are summarized in Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref> along with the number of subjects who completed the study. Out of 84 subjects pre-screened by interviews at the onset, 24 subjects did not meet the selection criteria either in laboratory tests and/or physical examinations. The remaining 60 subjects were randomly assigned to the KCJ (<italic>n=</italic>30) and placebo (<italic>n=</italic>30) groups. Four subjects (13%) from the KCJ group and three subjects (10%) from the placebo group failed to complete the study. Five subjects were disqualified because of inadequate intake of the prescribed supplements, and two subjects voluntarily withdrew due to personal reasons. A total of 53 subjects (KCJ=26, placebo=27) completed this study.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The Flow chart of the study.</p></caption><graphic xlink:href="1743-7075-10-24-1"/></fig></sec><sec><title>General characteristics of subjects and dietary assessment</title><p>The KCJ and placebo groups were similar in baseline characteristics (Table&#x000a0;
<xref ref-type="table" rid="T2">2</xref>). Significant differences between the two groups were observed in dietary intakes (calorie, carbohydrate, total protein) (Table&#x000a0;
<xref ref-type="table" rid="T3">3</xref>). But no significant interactions (treatment* time) were observed in the dietary intake of macro-and micro-nutrients.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Baseline characteristics of the subjects</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Variables</bold></th><th align="left"><bold>Kochujang group (n=30)</bold></th><th align="left"><bold>Placebo group (n=30)</bold></th><th align="left"><bold>P-value</bold><sup><bold>a</bold></sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Age (y)<hr/></td><td align="left" valign="bottom">42.1&#x000b1;1.3<sup>1</sup><hr/></td><td align="left" valign="bottom">43.0&#x000b1;2.2<hr/></td><td align="left" valign="bottom">0.786<hr/></td></tr><tr><td align="left" valign="bottom">Sex (M/F) <sup><bold>b</bold></sup><hr/></td><td align="left" valign="bottom">4/26<hr/></td><td align="left" valign="bottom">3/27<hr/></td><td align="left" valign="bottom">0.688<sup>b</sup><hr/></td></tr><tr><td align="left" valign="bottom">Weight (kg)<hr/></td><td align="left" valign="bottom">68.0&#x000b1;1.5<hr/></td><td align="left" valign="bottom">570.2&#x000b1;2.3<hr/></td><td align="left" valign="bottom">0.431<hr/></td></tr><tr><td align="left" valign="bottom">BMI (kg/m<sup>2</sup>)<hr/></td><td align="left" valign="bottom">26.7&#x000b1;0.4<hr/></td><td align="left" valign="bottom">27.4&#x000b1;0.8<hr/></td><td align="left" valign="bottom">0.383<hr/></td></tr><tr><td align="left" valign="bottom">WHR<hr/></td><td align="left" valign="bottom">0.91&#x000b1;0.005<hr/></td><td align="left" valign="bottom">0.90&#x000b1;0.006<hr/></td><td align="left" valign="bottom">0.242<hr/></td></tr><tr><td align="left" valign="bottom">Visceral fat (cm<sup>2</sup>)<hr/></td><td align="left" valign="bottom">79.0&#x000b1;5.1<hr/></td><td align="left" valign="bottom">78.3&#x000b1;4.4<hr/></td><td align="left" valign="bottom">0.926<hr/></td></tr><tr><td align="left" valign="bottom">Subcutaneous fat (cm<sup>2</sup>)<hr/></td><td align="left" valign="bottom">250.5&#x000b1;23.6<hr/></td><td align="left" valign="bottom">249.6&#x000b1;16.0<hr/></td><td align="left" valign="bottom">0.977<hr/></td></tr><tr><td align="left" valign="bottom">SBP (mmHg)<hr/></td><td align="left" valign="bottom">118.1&#x000b1;2.43<hr/></td><td align="left" valign="bottom">119.4&#x000b1;2.2<hr/></td><td align="left" valign="bottom">0.681<hr/></td></tr><tr><td align="left" valign="bottom">DBP(mmHg)<hr/></td><td align="left" valign="bottom">74.4&#x000b1;1.7<hr/></td><td align="left" valign="bottom">75.7&#x000b1;1.5<hr/></td><td align="left" valign="bottom">0.563<hr/></td></tr><tr><td align="left" valign="bottom">Pulse rate(bpm)<hr/></td><td align="left" valign="bottom">68.7&#x000b1;1.9<hr/></td><td align="left" valign="bottom">71.49&#x000b1;1.8<hr/></td><td align="left" valign="bottom">0.216<hr/></td></tr><tr><td align="left" valign="bottom">FPG(mg/dl)<hr/></td><td align="left" valign="bottom">83.3&#x000b1;1.6<hr/></td><td align="left" valign="bottom">81.6&#x000b1;1.5<hr/></td><td align="left" valign="bottom">0.449<hr/></td></tr><tr><td align="left" valign="bottom">HbA1c(%)<hr/></td><td align="left" valign="bottom">5.4&#x000b1;0.1<hr/></td><td align="left" valign="bottom">5.4&#x000b1;0.1<hr/></td><td align="left" valign="bottom">0.894<hr/></td></tr><tr><td align="left" valign="bottom">TC (mg/dL)<hr/></td><td align="left" valign="bottom">192.4&#x000b1;4.7<hr/></td><td align="left" valign="bottom">195.3&#x000b1;6.0<hr/></td><td align="left" valign="bottom">0.649<hr/></td></tr><tr><td align="left" valign="bottom">TG (mg/dL)<hr/></td><td align="left" valign="bottom">118.4&#x000b1;10.2<hr/></td><td align="left" valign="bottom">122.0&#x000b1;12.1<hr/></td><td align="left" valign="bottom">0.703<hr/></td></tr><tr><td align="left" valign="bottom">HDL (mg/dL)<hr/></td><td align="left" valign="bottom">52.0&#x000b1;1.7<hr/></td><td align="left" valign="bottom">52.5&#x000b1;2.1<hr/></td><td align="left" valign="bottom">0.822<hr/></td></tr><tr><td align="left" valign="bottom">LDL (mg/dL)<hr/></td><td align="left" valign="bottom">123.6&#x000b1;4.4<hr/></td><td align="left" valign="bottom">125.12&#x000b1;5.8<hr/></td><td align="left" valign="bottom">0.835<hr/></td></tr><tr><td align="left" valign="bottom">FFA (&#x003bc;Eq/L)<hr/></td><td align="left" valign="bottom">612.4&#x000b1;40.5<hr/></td><td align="left" valign="bottom">549.5&#x000b1;33.9<hr/></td><td align="left" valign="bottom">0.239<hr/></td></tr><tr><td align="left" valign="bottom">ApoA1 (g/dL)<hr/></td><td align="left" valign="bottom">1.44&#x000b1;0.03<hr/></td><td align="left" valign="bottom">1.45&#x000b1;0.04<hr/></td><td align="left" valign="bottom">0.770<hr/></td></tr><tr><td align="left">ApoB (g/dL)</td><td align="left">0.86&#x000b1;0.03</td><td align="left">0.87&#x000b1;0.04</td><td align="left">0.944</td></tr></tbody></table><table-wrap-foot><p><sup>1</sup> Values are expressed as means &#x000b1; SE.</p><p><sup>a</sup> By independent t test.</p><p><italic>BMI</italic> body mass index, <italic>WHR</italic> waist to hip ratio, <italic>TC</italic> total cholesterol, <italic>TG</italic> triglyceride, <italic>HDL</italic> high density lipoprotein cholesterol, <italic>LDL</italic> low density lipoprotein cholesterol, <italic>FFA</italic> free fatty acid, <italic>ApoA1</italic> Apolipoprotein A1, <italic>ApoB</italic> Apolipoprotein B., <italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>FPG</italic> fasting plasma glucose.</p><p><sup>b</sup> Chi-squate test. Statistical analyses were run with or without the men in the study, and also controlled for the gender as a covariate.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p><bold>Nutrient intakes of the </bold><bold><italic>Kochujang </italic></bold><bold>and placebo groups at the 0-wk and at 12-wk of the study</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Nutrients</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Kochujang group (n=30)</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Placebo group (n=30)</bold><hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>1</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>2</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>3</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>4</bold></sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Calorie(kcal/d)<hr/></td><td align="left" valign="bottom">1418.5&#x000b1;53.44<hr/></td><td align="left" valign="bottom">1393.1&#x000b1;92.9<hr/></td><td align="left" valign="bottom">-25.4&#x000b1;115.5<hr/></td><td align="left" valign="bottom">1527.1&#x000b1;58.3<hr/></td><td align="left" valign="bottom">1548.1&#x000b1;79.8<hr/></td><td align="left" valign="bottom">20.9&#x000b1;89.9<hr/></td><td align="left" valign="bottom">0.754<hr/></td><td align="left" valign="bottom">0172<hr/></td><td align="left" valign="bottom"><bold>0.028</bold><hr/></td><td align="left" valign="bottom">0.680<hr/></td></tr><tr><td align="left" valign="bottom">Carbohydrate(g/d)<hr/></td><td align="left" valign="bottom">222.8&#x000b1;8.2<hr/></td><td align="left" valign="bottom">208.2&#x000b1;10.3<hr/></td><td align="left" valign="bottom">-14.6&#x000b1;14.3<hr/></td><td align="left" valign="bottom">242.8&#x000b1;11.0<hr/></td><td align="left" valign="bottom">233.3&#x000b1;12.8<hr/></td><td align="left" valign="bottom">-9.5&#x000b1;16.5<hr/></td><td align="left" valign="bottom">0.816<hr/></td><td align="left" valign="bottom">0.070<hr/></td><td align="left" valign="bottom"><bold>0.030</bold><hr/></td><td align="left" valign="bottom">0.840<hr/></td></tr><tr><td align="left" valign="bottom">Total protein(g/d)<hr/></td><td align="left" valign="bottom">55.2&#x000b1;2.8<hr/></td><td align="left" valign="bottom">51.2&#x000b1;3.6<hr/></td><td align="left" valign="bottom">-3.9&#x000b1;4.9<hr/></td><td align="left" valign="bottom">60.7&#x000b1;2.2<hr/></td><td align="left" valign="bottom">57.9&#x000b1;5.0<hr/></td><td align="left" valign="bottom">-2.7&#x000b1;5.6<hr/></td><td align="left" valign="bottom">0.867<hr/></td><td align="left" valign="bottom">0.853<hr/></td><td align="left" valign="bottom"><bold>0.040</bold><hr/></td><td align="left" valign="bottom">0.823<hr/></td></tr><tr><td align="left" valign="bottom">Total lipid(g/d)<hr/></td><td align="left" valign="bottom">34.7&#x000b1;3.8<hr/></td><td align="left" valign="bottom">34.6&#x000b1;3.8<hr/></td><td align="left" valign="bottom">-0.1&#x000b1;4.7<hr/></td><td align="left" valign="bottom">37.6&#x000b1;1.7<hr/></td><td align="left" valign="bottom">37.3&#x000b1;3.5<hr/></td><td align="left" valign="bottom">-0.3&#x000b1;3.4<hr/></td><td align="left" valign="bottom">0.973<hr/></td><td align="left" valign="bottom">0.955<hr/></td><td align="left" valign="bottom">0.927<hr/></td><td align="left" valign="bottom">0.273<hr/></td></tr><tr><td align="left" valign="bottom">Fiber(g/d)<hr/></td><td align="left" valign="bottom">17.8&#x000b1;0.9<hr/></td><td align="left" valign="bottom">14.6&#x000b1;0.8<hr/></td><td align="left" valign="bottom">-3.2&#x000b1;1.3<hr/></td><td align="left" valign="bottom">19.3&#x000b1;1.1<hr/></td><td align="left" valign="bottom">18.3&#x000b1;1.4<hr/></td><td align="left" valign="bottom">-0.9&#x000b1;1.5<hr/></td><td align="left" valign="bottom">0.261<hr/></td><td align="left" valign="bottom">0.823<hr/></td><td align="left" valign="bottom"><bold>0.032</bold><hr/></td><td align="left" valign="bottom">0.273<hr/></td></tr><tr><td align="left" valign="bottom">Cholesterol(mg/d)<hr/></td><td align="left" valign="bottom">210.5&#x000b1;22.8<hr/></td><td align="left" valign="bottom">249.4&#x000b1;27.5<hr/></td><td align="left" valign="bottom">39.0&#x000b1;27.7<hr/></td><td align="left" valign="bottom">204.3&#x000b1;14.5<hr/></td><td align="left" valign="bottom">280.0&#x000b1;26.4<hr/></td><td align="left" valign="bottom">75.7&#x000b1;31.8<hr/></td><td align="left" valign="bottom">0.385<hr/></td><td align="left" valign="bottom">0.940<hr/></td><td align="left" valign="bottom">0.448<hr/></td><td align="left" valign="bottom">0.429<hr/></td></tr><tr><td align="left">Na(mg/d)</td><td align="left">3,630.4&#x000b1;247.4</td><td align="left">3,079.9&#x000b1;225.3</td><td align="left">-550.4&#x000b1;305.5</td><td align="left">3,665.9&#x000b1;191.2</td><td align="left">3697.1&#x000b1;220.4</td><td align="left">31.1&#x000b1;280.3</td><td align="left">0.168</td><td align="left">0.316</td><td align="left">0.164</td><td align="left">0.170</td></tr></tbody></table><table-wrap-foot><p>All values are expressed as means &#x000b1; SE.</p><p>P value<sup>1</sup>, <italic>t</italic>-test between changes of the Kocujinag and placebo group : P value<sup>2,3,4</sup> time, group and interaction(time*group) effect of two-way repeated measure ANOVA, after adjusting for age and gender.</p><p><sup>*</sup> Change = 12 wk &#x02013; 0wk.</p><p>&#x02020; Paired <italic>t</italic>-test between 0-wk and 12-wk <italic>(P&#x0003c;0.05)</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Body weight and components</title><p>Body weight and body composition data of both KCJ and placebo groups are summarized in the upper part of Table&#x000a0;
<xref ref-type="table" rid="T4">4</xref>. After 12 weeks of KCJ supplementation, no significant changes were observed in body weight, BMI, body fat mass (kg), body fat (%) and WHR.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p><bold>Change of body weight,body composition,abdominal fat area, </bold><bold><italic>index in glycaemic control factor </italic></bold><bold>and blood pressure measurements at the 0-wk and 12-wk of the study</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Parameters</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Kochujang group (n=30)</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Placebo group (n=30)</bold><hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>P&#x000a0;value</bold><sup><bold>1</bold></sup></th><th align="left"><bold>P&#x000a0;value</bold><sup><bold>2</bold></sup></th><th align="left"><bold>P&#x000a0;value</bold><sup><bold>3</bold></sup></th><th align="left"><bold>P&#x000a0;value</bold><sup><bold>4</bold></sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Body weight (kg)<hr/></td><td align="left" valign="bottom">66.6&#x000b1;1.4<hr/></td><td align="left" valign="bottom">66.6&#x000b1;1.4<hr/></td><td align="left" valign="bottom">0.06&#x000b1;0.3<hr/></td><td align="left" valign="bottom">68.5&#x000b1;2.4<hr/></td><td align="left" valign="bottom">68.8&#x000b1;2.5<hr/></td><td align="left" valign="bottom">0.3&#x000b1;0.3<hr/></td><td align="left" valign="bottom">0.577<hr/></td><td align="left" valign="bottom">0.140<hr/></td><td align="left" valign="bottom">0.244<hr/></td><td align="left" valign="bottom">0.439<hr/></td></tr><tr><td align="left" valign="bottom">Body fat mass (kg)<hr/></td><td align="left" valign="bottom">22.3&#x000b1;0.7<hr/></td><td align="left" valign="bottom">22.0&#x000b1;0.8<hr/></td><td align="left" valign="bottom">-0.3&#x000b1;0.3<hr/></td><td align="left" valign="bottom">24.5&#x000b1;1.6<hr/></td><td align="left" valign="bottom">24.5&#x000b1;1.6<hr/></td><td align="left" valign="bottom">0.0&#x000b1;0.0<hr/></td><td align="left" valign="bottom">0.476<hr/></td><td align="left" valign="bottom">0.480<hr/></td><td align="left" valign="bottom">0.172<hr/></td><td align="left" valign="bottom">0.391<hr/></td></tr><tr><td align="left" valign="bottom">Body fat (%)<hr/></td><td align="left" valign="bottom">33.4&#x000b1;0.8<hr/></td><td align="left" valign="bottom">33.0&#x000b1;0.9<hr/></td><td align="left" valign="bottom">-0.4&#x000b1;0.4<hr/></td><td align="left" valign="bottom">34.7&#x000b1;.0.9<hr/></td><td align="left" valign="bottom">34.6&#x000b1;0.9<hr/></td><td align="left" valign="bottom">-0.1&#x000b1;0.2<hr/></td><td align="left" valign="bottom">0.498<hr/></td><td align="left" valign="bottom">0.351<hr/></td><td align="left" valign="bottom">0.391<hr/></td><td align="left" valign="bottom">0.413<hr/></td></tr><tr><td align="left" valign="bottom">BMI<hr/></td><td align="left" valign="bottom">26.5&#x000b1;0.4<hr/></td><td align="left" valign="bottom">26.4&#x000b1;0.4<hr/></td><td align="left" valign="bottom">-0.1&#x000b1;0.1<hr/></td><td align="left" valign="bottom">27.4&#x000b1;0.8<hr/></td><td align="left" valign="bottom">27.5&#x000b1;0.9<hr/></td><td align="left" valign="bottom">0.03&#x000b1;0.0<hr/></td><td align="left" valign="bottom">0.606<hr/></td><td align="left" valign="bottom">0.692<hr/></td><td align="left" valign="bottom">0.248<hr/></td><td align="left" valign="bottom">0.544<hr/></td></tr><tr><td align="left" valign="bottom">WHR<hr/></td><td align="left" valign="bottom">0.91&#x000b1;0.006<hr/></td><td align="left" valign="bottom">0.89&#x000b1;0.009<hr/></td><td align="left" valign="bottom">-0.1&#x000b1;0.1<hr/></td><td align="left" valign="bottom">0.90&#x000b1;0.007<hr/></td><td align="left" valign="bottom">0.90&#x000b1;0.01<hr/></td><td align="left" valign="bottom">0.1&#x000b1;0.009<hr/></td><td align="left" valign="bottom">0.351<hr/></td><td align="left" valign="bottom">0.692<hr/></td><td align="left" valign="bottom">0.475<hr/></td><td align="left" valign="bottom">0.274<hr/></td></tr><tr><td align="left" valign="bottom">Total fat (cm<sup>2</sup>)<hr/></td><td align="left" valign="bottom">333.4&#x000b1;29.6<hr/></td><td align="left" valign="bottom">280.6&#x000b1;28.8<hr/></td><td align="left" valign="bottom">-52.8&#x000b1;33.3<hr/></td><td align="left" valign="bottom">324.8&#x000b1;17.9<hr/></td><td align="left" valign="bottom"><bold>272.1&#x000b1;12.6</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-52.8&#x000b1;6.2<hr/></td><td align="left" valign="bottom">0.998<hr/></td><td align="left" valign="bottom">0.187<hr/></td><td align="left" valign="bottom">0.680<hr/></td><td align="left" valign="bottom">0.972<hr/></td></tr><tr><td align="left" valign="bottom">Visceral fat (cm<sup>2</sup>)<hr/></td><td align="left" valign="bottom">81.1&#x000b1;5.5<hr/></td><td align="left" valign="bottom"><bold>76.2&#x000b1;5.6</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-4.8&#x000b1;3.3<hr/></td><td align="left" valign="bottom">78.4&#x000b1;4.8<hr/></td><td align="left" valign="bottom">78.9&#x000b1;4.3<hr/></td><td align="left" valign="bottom">0.4&#x000b1;2.1<hr/></td><td align="left" valign="bottom"><bold>0.043</bold><hr/></td><td align="left" valign="bottom"><bold>0.001</bold><hr/></td><td align="left" valign="bottom">0.974<hr/></td><td align="left" valign="bottom"><bold>0.038</bold><hr/></td></tr><tr><td align="left" valign="bottom">Subcutaneous fat (cm<sup>2</sup>)<hr/></td><td align="left" valign="bottom">252.3&#x000b1;27.1<hr/></td><td align="left" valign="bottom">204.4&#x000b1;26.7<hr/></td><td align="left" valign="bottom">-47.9&#x000b1;33.4<hr/></td><td align="left" valign="bottom">246.4&#x000b1;17.0<hr/></td><td align="left" valign="bottom"><bold>193.2&#x000b1;11.1</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-53.2&#x000b1;6.6<hr/></td><td align="left" valign="bottom">0.875<hr/></td><td align="left" valign="bottom">0.107<hr/></td><td align="left" valign="bottom">0.649<hr/></td><td align="left" valign="bottom">0.869<hr/></td></tr><tr><td align="left" valign="bottom">VSR<hr/></td><td align="left" valign="bottom">0.37&#x000b1;0.03<hr/></td><td align="left" valign="bottom"><bold>0.42&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">0.05&#x000b1;0.02<hr/></td><td align="left" valign="bottom">0.36&#x000b1;0.01<hr/></td><td align="left" valign="bottom"><bold>0.44&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">0.08&#x000b1;0.01<hr/></td><td align="left" valign="bottom">0.218<hr/></td><td align="left" valign="bottom"><bold>0.001</bold><hr/></td><td align="left" valign="bottom">0.849<hr/></td><td align="left" valign="bottom">0.302<hr/></td></tr><tr><td align="left" valign="bottom">SBP (mmHg)<hr/></td><td align="left" valign="bottom">117.3&#x000b1;2.4<hr/></td><td align="left" valign="bottom">120.3&#x000b1;2.4<hr/></td><td align="left" valign="bottom">2.9&#x000b1;2.4<hr/></td><td align="left" valign="bottom">119.3&#x000b1;2.3<hr/></td><td align="left" valign="bottom">119.7&#x000b1;2.4<hr/></td><td align="left" valign="bottom">0.4&#x000b1;1.5<hr/></td><td align="left" valign="bottom">0.367<hr/></td><td align="left" valign="bottom">0.260<hr/></td><td align="left" valign="bottom">0.706<hr/></td><td align="left" valign="bottom">0.447<hr/></td></tr><tr><td align="left" valign="bottom">DBP(mmHg)<hr/></td><td align="left" valign="bottom">74.5&#x000b1;1.9<hr/></td><td align="left" valign="bottom">75.4&#x000b1;1.9<hr/></td><td align="left" valign="bottom">0.9&#x000b1;1.9<hr/></td><td align="left" valign="bottom">75.6&#x000b1;1.6<hr/></td><td align="left" valign="bottom">76.9&#x000b1;2.1<hr/></td><td align="left" valign="bottom">1.3&#x000b1;1.5<hr/></td><td align="left" valign="bottom">0.880<hr/></td><td align="left" valign="bottom">0.877<hr/></td><td align="left" valign="bottom">0.548<hr/></td><td align="left" valign="bottom">0.813<hr/></td></tr><tr><td align="left" valign="bottom">Pulse rate(bpm)<hr/></td><td align="left" valign="bottom">68.8&#x000b1;2.1<hr/></td><td align="left" valign="bottom">68.4&#x000b1;1.6<hr/></td><td align="left" valign="bottom">-0.4&#x000b1;1.3<hr/></td><td align="left" valign="bottom">71.4&#x000b1;1.8<hr/></td><td align="left" valign="bottom">71.5&#x000b1;2.0<hr/></td><td align="left" valign="bottom">0.1&#x000b1;1.4<hr/></td><td align="left" valign="bottom">0.748<hr/></td><td align="left" valign="bottom">0.506<hr/></td><td align="left" valign="bottom">0.272<hr/></td><td align="left" valign="bottom">0.726<hr/></td></tr><tr><td align="left" valign="bottom">FPG(mg/dl)<hr/></td><td align="left" valign="bottom">84.6&#x000b1;1.6<hr/></td><td align="left" valign="bottom">80.7&#x000b1;1.8<hr/></td><td align="left" valign="bottom">-3.8&#x000b1;1.1<hr/></td><td align="left" valign="bottom">81.6&#x000b1;1.6<hr/></td><td align="left" valign="bottom">79.6&#x000b1;1.9<hr/></td><td align="left" valign="bottom">-1.9&#x000b1;1.0<hr/></td><td align="left" valign="bottom">0.217<hr/></td><td align="left" valign="bottom">0.056<hr/></td><td align="left" valign="bottom">0.454<hr/></td><td align="left" valign="bottom">0.188<hr/></td></tr><tr><td align="left">HbA1c(%)</td><td align="left">5.42&#x000b1;0.03</td><td align="left">5.42&#x000b1;0.08</td><td align="left">0.007&#x000b1;0.05</td><td align="left">5.42&#x000b1;0.01</td><td align="left">5.47&#x000b1;0.01</td><td align="left">0.05&#x000b1;0.06</td><td align="left">0.607</td><td align="left">0.567</td><td align="left">0.673</td><td align="left">0.681</td></tr></tbody></table><table-wrap-foot><p>All values are expressed as means &#x000b1; SE.</p><p><italic>WHR</italic> waist to hip ratio, <italic>VSR</italic> Visceral adipose tissue to subcutaneous adipose tissue ratio.</p><p>P value<sup>1</sup>, <italic>t</italic>-test between changes of the Kocujinag and placebo group : P value<sup>2,3,4</sup> time, group and interaction(time*group) effect of two-way repeated measure ANOVA, after adjusting for age and gender.</p><p><sup>*</sup> Change = 12 wk &#x02013; 0wk.</p><p>&#x02020; Paired <italic>t</italic>-test between 0-wk and 12-wk <italic>(P&#x0003c;0.05)</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Abdominal fat distribution by computerized tomography</title><p>Abdominal fat distributions measured by computerized tomography are shown in the lower part of Table&#x000a0;
<xref ref-type="table" rid="T4">4</xref>. After 12-week of intervention, the KCJ group showed a significant reduction in visceral fat area compared to the placebo group. Furthermore, significant differences were observed in the visceral fat area from baseline to 12 weeks in both groups. The KCJ group attained a difference of -4.8cm<sup>2</sup> whereas placebo group showed 0.4 cm<sup>2</sup> changes in the visceral fat area. Both the change in visceral/subcutaneous fat ratio decreased from baseline to 12 weeks (p&#x0003c;0.05). Furthermore, a significant interaction (time * group) were observed in the visceral fat area (p&#x0003c;0.038).</p></sec><sec><title>Blood lipid profiles and atherosclerosis index</title><p>As shown in Table&#x000a0;
<xref ref-type="table" rid="T5">5</xref>, the mean difference in TG, ApoA1 and ApoB from baseline to 12 weeks were -17.9, -0.18 and -0.17, respectively in the KCJ group compared with 13.5, -0.14 and -0.12, respectively in the placebo group. A significant difference in the TG (<italic>p</italic>=0.026) level was observed between the two groups. Along with a significant interaction (time *group) in the difference of TG (<italic>p</italic>=0.042) between the two groups.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p><bold>Serum lipid profiles of the </bold><bold><italic>Kochujang </italic></bold><bold>and placebo groups at the 0-wk and at 12-wk of the study</bold></p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left" valign="bottom"><bold>Parameters</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Kochujang group (n=30)</bold><hr/></th><th colspan="3" align="left" valign="bottom"><bold>Placebo group (n=30)</bold><hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th><th align="left" valign="bottom">&#x000a0;<hr/></th></tr><tr><th align="left">&#x000a0;</th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>0wk</bold></th><th align="left"><bold>12wk</bold></th><th align="left"><bold>Change</bold><sup><bold>*</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>1</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>2</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>3</bold></sup></th><th align="left"><bold>P value</bold><sup><bold>41</bold></sup></th></tr></thead><tbody><tr><td align="left" valign="bottom">Total cholesterol(mg/dL)<hr/></td><td align="left" valign="bottom">193.4&#x000b1;5.1<hr/></td><td align="left" valign="bottom">189.8&#x000b1;5.9<hr/></td><td align="left" valign="bottom">-3.6&#x000b1;3.9<hr/></td><td align="left" valign="bottom">196.4&#x000b1;6.3<hr/></td><td align="left" valign="bottom">197.9&#x000b1;5.1<hr/></td><td align="left" valign="bottom">1.5&#x000b1;4.2<hr/></td><td align="left" valign="bottom">0.378<hr/></td><td align="left" valign="bottom"><bold>0.047</bold><hr/></td><td align="left" valign="bottom">0.740<hr/></td><td align="left" valign="bottom">0.367<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Triglycerides(mg/dL)</bold><hr/></td><td align="left" valign="bottom">112.5&#x000b1;9.1<hr/></td><td align="left" valign="bottom"><bold>94.6&#x000b1;5.8</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-17.9&#x000b1;8.5<hr/></td><td align="left" valign="bottom">125.6&#x000b1;12.7<hr/></td><td align="left" valign="bottom">139.1&#x000b1;13.8<hr/></td><td align="left" valign="bottom">13.5&#x000b1;12.9<hr/></td><td align="left" valign="bottom"><bold>0.049</bold><hr/></td><td align="left" valign="bottom">0.412<hr/></td><td align="left" valign="bottom"><bold>0.026</bold><hr/></td><td align="left" valign="bottom"><bold>0.042</bold><hr/></td></tr><tr><td align="left" valign="bottom">HDL (mg/dL)<hr/></td><td align="left" valign="bottom">52.3&#x000b1;1.9<hr/></td><td align="left" valign="bottom">51.2&#x000b1;1.9<hr/></td><td align="left" valign="bottom">-1.07&#x000b1;1.5<hr/></td><td align="left" valign="bottom">52.3&#x000b1;2.2<hr/></td><td align="left" valign="bottom">50.9&#x000b1;1.8<hr/></td><td align="left" valign="bottom">-1.32&#x000b1;1.7<hr/></td><td align="left" valign="bottom">0.912<hr/></td><td align="left" valign="bottom">0.100<hr/></td><td align="left" valign="bottom">0.923<hr/></td><td align="left" valign="bottom">0.670<hr/></td></tr><tr><td align="left" valign="bottom">LDL (mg/dL))<hr/></td><td align="left" valign="bottom">124.9&#x000b1;4.7<hr/></td><td align="left" valign="bottom">122.3&#x000b1;5.2<hr/></td><td align="left" valign="bottom">-0.25&#x000b1;0.14<hr/></td><td align="left" valign="bottom">125.9&#x000b1;6.1<hr/></td><td align="left" valign="bottom">123.6&#x000b1;5.3<hr/></td><td align="left" valign="bottom">-0.15&#x000b1;0.14<hr/></td><td align="left" valign="bottom">0.630<hr/></td><td align="left" valign="bottom">0.188<hr/></td><td align="left" valign="bottom">0.874<hr/></td><td align="left" valign="bottom">0.960<hr/></td></tr><tr><td align="left" valign="bottom">Free fatty acid (&#x003bc;Eq/L)<hr/></td><td align="left" valign="bottom">631.8&#x000b1;43.2<hr/></td><td align="left" valign="bottom">604.7&#x000b1;37.4<hr/></td><td align="left" valign="bottom">-27.1&#x000b1;53.9<hr/></td><td align="left" valign="bottom">542.2&#x000b1;34.7<hr/></td><td align="left" valign="bottom">631.9&#x000b1;43.0<hr/></td><td align="left" valign="bottom">89.8&#x000b1;44.0<hr/></td><td align="left" valign="bottom">0.098<hr/></td><td align="left" valign="bottom">0.658<hr/></td><td align="left" valign="bottom">0.669<hr/></td><td align="left" valign="bottom">0.170<hr/></td></tr><tr><td align="left" valign="bottom">ApoA1 (g/dL)<hr/></td><td align="left" valign="bottom">1.44&#x000b1;0.03<hr/></td><td align="left" valign="bottom"><bold>1.26&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-0.18&#x000b1;0.03<hr/></td><td align="left" valign="bottom">1.45&#x000b1;0.04<hr/></td><td align="left" valign="bottom"><bold>1.31&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-0.14&#x000b1;0.03<hr/></td><td align="left" valign="bottom">0.284<hr/></td><td align="left" valign="bottom"><bold>0.002</bold><hr/></td><td align="left" valign="bottom">0.729<hr/></td><td align="left" valign="bottom">0.216<hr/></td></tr><tr><td align="left" valign="bottom">ApoB(g/dL)<hr/></td><td align="left" valign="bottom">0.87&#x000b1;0.03<hr/></td><td align="left" valign="bottom"><bold>0.70&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-0.17&#x000b1;0.02<hr/></td><td align="left" valign="bottom">0.88&#x000b1;0.04<hr/></td><td align="left" valign="bottom"><bold>0.76&#x000b1;0.04</bold><sup><bold>&#x02020;</bold></sup><hr/></td><td align="left" valign="bottom">-0.12&#x000b1;0.02<hr/></td><td align="left" valign="bottom"><bold>0.049</bold><hr/></td><td align="left" valign="bottom"><bold>0.001</bold><hr/></td><td align="left" valign="bottom">0.540<hr/></td><td align="left" valign="bottom"><bold>0.025</bold><hr/></td></tr><tr><td align="left" valign="bottom">Atherosclerosis Indices<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">TC/HDL<hr/></td><td align="left" valign="bottom">3.8&#x000b1;0.1<hr/></td><td align="left" valign="bottom">3.4&#x000b1;0.2<hr/></td><td align="left" valign="bottom">-0.42&#x000b1;0.2<hr/></td><td align="left" valign="bottom">3.9&#x000b1;0.2<hr/></td><td align="left" valign="bottom">3.8&#x000b1;0.2<hr/></td><td align="left" valign="bottom">-0.10&#x000b1;0.2<hr/></td><td align="left" valign="bottom">0.303<hr/></td><td align="left" valign="bottom">0.935<hr/></td><td align="left" valign="bottom">0.460<hr/></td><td align="left" valign="bottom">0.357<hr/></td></tr><tr><td align="left" valign="bottom">LDL/HDL<hr/></td><td align="left" valign="bottom">2.4&#x000b1;0.1<hr/></td><td align="left" valign="bottom">2.2&#x000b1;0.1<hr/></td><td align="left" valign="bottom">-0.25&#x000b1;0.1<hr/></td><td align="left" valign="bottom">2.5&#x000b1;0.2<hr/></td><td align="left" valign="bottom">2.3&#x000b1;0.2<hr/></td><td align="left" valign="bottom">-0.15&#x000b1;0.1<hr/></td><td align="left" valign="bottom">0.630<hr/></td><td align="left" valign="bottom">0.976<hr/></td><td align="left" valign="bottom">0.671<hr/></td><td align="left" valign="bottom">0.752<hr/></td></tr><tr><td align="left" valign="bottom">(TC-HDL)/HDL<hr/></td><td align="left" valign="bottom">2.8&#x000b1;0.1<hr/></td><td align="left" valign="bottom">2.5&#x000b1;0.2<hr/></td><td align="left" valign="bottom">-0.32&#x000b1;0.2<hr/></td><td align="left" valign="bottom">2.9&#x000b1;0.2<hr/></td><td align="left" valign="bottom">2.8&#x000b1;0.2<hr/></td><td align="left" valign="bottom">-0.04&#x000b1;0.03<hr/></td><td align="left" valign="bottom">0.253<hr/></td><td align="left" valign="bottom">0.975<hr/></td><td align="left" valign="bottom">0.454<hr/></td><td align="left" valign="bottom">0.297<hr/></td></tr><tr><td align="left">ApoB/ApoA1</td><td align="left">0.61&#x000b1;0.02</td><td align="left"><bold>0.56&#x000b1;0.03</bold><sup><bold>&#x02020;</bold></sup></td><td align="left">-0.05&#x000b1;0.01</td><td align="left">0.61&#x000b1;0.03</td><td align="left">0.60&#x000b1;0.03</td><td align="left">-0.01&#x000b1;0.02</td><td align="left">0.296</td><td align="left">0.075</td><td align="left">0.240</td><td align="left">0.593</td></tr></tbody></table><table-wrap-foot><p>All values are expressed as means &#x000b1; SE.</p><p><italic>HDL</italic> High-density lipoprotein cholesterol, <italic>LDL</italic> Low-density lipoprotein cholesterol, <italic>ApoA1</italic> Apolipoprotein A1, <italic>ApoB</italic> Apolipoprotein B, <italic>TC/HDL</italic> total cholesterol/high density lipoprotein cholesterol ratio, <italic>LDL/HDL</italic> low density lipoprotein/cholesterol high density lipoprotein cholesterol ratio, <italic>(TC-HDL)/HDL</italic> (total cholesterol - high density lipoprotein cholesterol)/high density lipoprotein cholesterol ratio;</p><p><italic>ApoB/ApoA1</italic> Apolipoprotein B/Apolipoprotein A1.</p><p>P value<sup>1</sup>, <italic>t</italic>-test between changes of the Kocujinag and placebo group : P value<sup>2,3,4</sup> time, group and interaction (time*group) effect of two-way repeated measure ANOVA, after adjusting for age and gender.</p><p><sup>*</sup> Change = 12 &#x02013;wk &#x02013; 0-wk.</p><p>&#x02020; Paired <italic>t</italic>-test between 0-wk and 12-wk <italic>(P&#x0003c;0.05)</italic>.</p></table-wrap-foot></table-wrap><p>Apo B level showed no changes in the baseline and 12weeks in either group, however a significant difference was observed (p=0.049) between the two groups. While no significant interaction (time*group) were found in Apo B levels. There was no significant changes or differences observed in serum TC, HDL, LDL, ApoA1, ApoB and FFA level between the two groups. The changes in TC/HDL and (TC-HDL) /HDL ratio (Table&#x000a0;
<xref ref-type="table" rid="T5">5</xref>) from baseline to 12-week were 0.42 and -0.32, in the KCJ group compared with -0.10 and -0.04, in the placebo group, however, these changes were not significant. ApoB/ApoA<sub>1</sub> ratio also showed no changes between the baseline and 12weeks in either group, but a reduction in the ratio was observed in the KCJ groups from baseline to 12 weeks.</p></sec><sec><title>Safety measurements</title><p>The overall safety measures obtained before and after the intervention indicated no significant changes during the study (data not shown). The evaluations were also expanded to laboratory tests, electrocardiogram and vital signs (blood pressure, pulse) during the subjects&#x02019; visits.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>We hypothesized that KCJ supplementation for 12 weeks would reduce body fat and improve blood lipid profiles in overweight adults, as demonstrated in animal studies
[<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. In this clinical trial, we found no significant effects on body weight (kg), body fat (%) or WHR after 12 weeks of KCJ supplementation. However, CT scans did reveal significant reductions in visceral fat area after KCJ supplementation. Furthermore, visceral fat area of the KCJ group was significantly lower than that of the placebo (Table&#x000a0;
<xref ref-type="table" rid="T4">4</xref>). In our study we did not control the lifestyle of the subjects. Apart from the KCJ group, the placebo group also showed changes in certain parameter like total fat and subcutaneous fat, however these changes were not significant. Placebo causes psychological effects rather than the effect caused by its ingredients
[<xref ref-type="bibr" rid="B30">30</xref>].</p><p>Many studies evaluate the effects of specific bioactive compounds or ingredients such as isoflavones, capsaicine, capsioids and red pepper power in subjects as adjuncts with additive effects of dietary intervention in a group of subjects following a weight loss program. This study took a different approach. The present study aimed to examine the biological outcome in humans resulting from the synergistic effects of functional compounds that constitute KCJ as a whole food, rather than those of the individual components in KCJ. We therefore evaluated the effect of supplementing a traditional food, KCJ, along with the diet of overweight subjects following a normal diet and lifestyle. Our subjects did not experience a great degree of overall weight loss as seen in some studies using higher doses of bioactive compounds, but did experience a very significant decrease in visceral fat with concomitant improvements in risk factors for cardiovascular disease (Table&#x000a0;
<xref ref-type="table" rid="T4">4</xref>). Visceral adiposity is known to be associated with an elevated ApoB/ApoA<sub>1</sub> ratio with is considered to be a risk factor for metabolic syndrome
[<xref ref-type="bibr" rid="B31">31</xref>]. Therefore, our results showing decreased visceral adiposity and decreased ApoB is consistent with a protective effect of KCJ against the development of metabolic syndrome. Our findings are similar to those in other studies in which adults (30~60 y of age) who ingested capsinoid (6&#x02009;mg/d) orally lost abdominal fat and had increased fat oxidation
[<xref ref-type="bibr" rid="B32">32</xref>]. In a study of obese college women who consumed red pepper extracts, the subjects lost both body weight and body fat
[<xref ref-type="bibr" rid="B33">33</xref>]. The college women were closely monitored for their dietary intake through repeated education and weekly reminders. The close monitoring of dietary intake is believed to have resulted in changes in body weight and body fat composition.</p><p>Other studies have also reported that daily supplementation of L-carnitine (300 mg) and isoflavones (400 mg) for 12 weeks decreased visceral fat
[<xref ref-type="bibr" rid="B34">34</xref>]. Wu et al (2006) reported that isoflavon supplementation for one year resulted in no differences in body mass or body fat, but trunk fat mass decreased significantly
[<xref ref-type="bibr" rid="B35">35</xref>]. Apart from single bioactive components supplement mediated anti-obesity effect, whole food like fermented soybean paste <italic>doenjang</italic> also reported to have anti-obesity effect in human obese subjects
[<xref ref-type="bibr" rid="B36">36</xref>]. A Study using fermented kimchi powder as whole food mixed in animal diet proved to be beneficial in limiting weight gain in rodent models
[<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Although statistically insignificant, the changes in mean energy intake in the KCJ group decreased over 12 weeks while that in the placebo group increased (Table&#x000a0;
<xref ref-type="table" rid="T3">3</xref>). It is thus possible that capsaicin or other bioactive components in KJC might have functioned as appetite suppressants. Serum TG levels decreased in the KCJ supplemented group in contrast to those of the placebo group (Table&#x000a0;
<xref ref-type="table" rid="T5">5</xref>). Similar results have been reported when overweight women were supplemented with L-carnitine and isoflavon. Capsaicin supplementation (0.014% wt or 3mg %) with a high fat diet in mice has also been reported to decrease blood TG, with no changes in TC levels
[<xref ref-type="bibr" rid="B38">38</xref>]. In this study, KCJ supplementation resulted in beneficial effects on TG and ApoB(p&#x0003c;0.05). A study on healthy adults with Kimchi supplementation reported no changes in the LDL-C/HDL-C&#x02009;
[<xref ref-type="bibr" rid="B39">39</xref>], but supplementation of isoflavon for 12 weeks significantly decreased the (TC-HDL)/HDL
[<xref ref-type="bibr" rid="B34">34</xref>]. The profound effect of KCJ on visceral adiposity and atherogenic indices observed in the present study might have been mediated through one or more of the bioactive compounds in KCJ such as capsaicin in red pepper, isoflavon aglycones, and peptides from fermented soy
[<xref ref-type="bibr" rid="B40">40</xref>]. Capsaicin has been reported to upregulate lipolysis and thermogenesis while suppressing appetite
[<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. Isoflavones such as genestein increases lipid oxidation with upregulated CPT-1 and activation of PPAR-&#x003b1;
[<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>].</p><p>As the people with obesity and overweight tend to develop hypertension, the salt content of KCJ (Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>) may be of concern. According to KNHANES study
[<xref ref-type="bibr" rid="B43">43</xref>] (2010), the daily salt intake of all Koreans (including children and the elderly) averages 12.1g/day (4,878 mg Na). In the present study salt intake of the adult subjects from regular meals (~ 8.5&#x02009;g/day) and KCJ supplement (~ 6&#x02009;g/day) was ~14.5&#x02009;g/day (5,800 mg Na) which is 16.55% higher than the mean daily intake by all Koreans. Sodium excretion of the two groups in the present study, before and after the intervention, did not show any significant change.</p><p>KCJ could be helpful in utilizing it as ketchup or sauce in western diets. It can be used an a spicy ingredient in many dishes worldwide. Despite the concern of salt content of KCJ, we observed the therapeutic benefits of KCJ in our adult subjects. These findings suggest that KCJ may have the potential to be developed as a whole food, nutraceutical or functional supplement for the management of obesity in some population.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Decreased visceral adiposity and improved atherosclerosis indices were observed after overweight adults received KCJ supplementation for 12 weeks. The unique strength of this study was the observation of biological effect of KCJ, a whole food, in free-living overweight adults. However, the mechanisms responsible for these observed effects are yet to be elucidated.</p></sec><sec><title>Competing interests</title><p>None of the above authors have conflicts of interest.</p></sec><sec><title>Authors&#x02019; contributions</title><p>All authors had participated in this work with substantive contributions. Soo-Ran Kim Ji-Ae Yang, Hyang-Im Back, and Min-Gul Kim had the responsibility to carry out the daily responsibility of the RCT projects. Drs. Soo-Wan Chae, Won O Song, and Youn-Soo Cha had participated in biochemical analysis, interpretation of data. Dr. Su-Jin Jung carried out the statistical analysis. All authors read and approved the final manuscript.</p></sec><sec><title>Funding sources</title><p>This study was supported by grants from the Ministry for Food, Agriculture, Forestry and Fisheries (20080410496-00) and research funds of Chonbuk National University in 2011.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>KJ</given-names></name><article-title>Analysis of the relationship between dietary fiber intake and food habits in the korean adult population</article-title><source>The Korean J Nutr</source><year>2008</year><volume>41</volume><fpage>19</fpage></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>EH</given-names></name><article-title>A study on health related action rates of dietary guidelines and pattern of dietary in middle-aged women</article-title><source>J Korean Soc Health Inform Health Stat</source><year>2009</year><volume>34</volume><fpage>12</fpage></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Jang</surname><given-names>JS</given-names></name><article-title>Antecedent intake of traditional Asian-style diets exacerbates pancreatic beta-cell function, growth and survival after Western-style diet feeding in weaning male rats</article-title><source>J Nutr Biochem</source><year>2006</year><volume>17</volume><fpage>307</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2005.07.002</pub-id><pub-id pub-id-type="pmid">16223578</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name><article-title>Biologically active components of soy-fermented foods</article-title><source>Korean Soybean Digest</source><year>2002</year><volume>17</volume><fpage>7</fpage></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><article-title>Changes in microorganisms, enzyme activities, and gas formation by the addition of mustard power on Kochujang with different salt concentration</article-title><source>Food Sci Biotechnol</source><year>2006</year><volume>15</volume><fpage>298</fpage><lpage>302</lpage></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>DY</given-names></name><name><surname>Hong</surname><given-names>SM</given-names></name><name><surname>Ahn</surname><given-names>IS</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Shin</surname><given-names>DW</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><article-title>Kochujang, a Korean fermented red pepper plus soybean paste, improves glucose homeostasis in 90% pancreatectomized diabetic rats</article-title><source>Nutrition</source><year>2009</year><volume>25</volume><fpage>790</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2008.12.006</pub-id><pub-id pub-id-type="pmid">19251395</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Kawada</surname><given-names>T</given-names></name><name><surname>Hagihara</surname><given-names>K</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><article-title>Effects of capsaicin on lipid metabolism in rats fed a high fat diet</article-title><source>J Nutr</source><year>1986</year><volume>116</volume><fpage>1272</fpage><lpage>1278</lpage><pub-id pub-id-type="pmid">2875141</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Han</surname><given-names>IS</given-names></name><name><surname>Kawada</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Yu</surname><given-names>R</given-names></name><article-title>Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet</article-title><source>Obesity (Silver Spring)</source><year>2010</year><volume>18</volume><fpage>780</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1038/oby.2009.301</pub-id><pub-id pub-id-type="pmid">19798065</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Ahn</surname><given-names>IS</given-names></name><name><surname>Do</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>SO</given-names></name><name><surname>Jung</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>YI</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>KY</given-names></name><article-title>Antiobesity effect of Kochujang (Korean fermented red pepper paste) extract in 3T3-L1 adipocytes</article-title><source>J Med Food</source><year>2006</year><volume>9</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1089/jmf.2006.9.15</pub-id><pub-id pub-id-type="pmid">16579723</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Kawada</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><article-title>Effects of capsaicin analogs on adrenal catecholamine secretion in rats</article-title><source>Life Sci</source><year>1994</year><volume>54</volume><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(94)00793-4</pub-id><pub-id pub-id-type="pmid">8289598</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Ahuja</surname><given-names>KD</given-names></name><name><surname>Robertson</surname><given-names>IK</given-names></name><name><surname>Geraghty</surname><given-names>DP</given-names></name><name><surname>Ball</surname><given-names>MJ</given-names></name><article-title>Effects of chili consumption on postprandial glucose, insulin, and energy metabolism</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>84</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">16825682</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Spiller</surname><given-names>F</given-names></name><name><surname>Alves</surname><given-names>MK</given-names></name><name><surname>Vieira</surname><given-names>SM</given-names></name><name><surname>Carvalho</surname><given-names>TA</given-names></name><name><surname>Leite</surname><given-names>CE</given-names></name><name><surname>Lunardelli</surname><given-names>A</given-names></name><name><surname>Poloni</surname><given-names>JA</given-names></name><name><surname>Cunha</surname><given-names>FQ</given-names></name><name><surname>de Oliveira</surname><given-names>JR</given-names></name><article-title>Anti-inflammatory effects of red pepper (Capsicum baccatum) on carrageenan- and antigen-induced inflammation</article-title><source>J Pharm Pharmacol</source><year>2008</year><volume>60</volume><fpage>473</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1211/jpp.60.4.0010</pub-id><pub-id pub-id-type="pmid">18380920</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Choo</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>H</given-names></name><article-title>Body-fat suppressive effects of capsaicin through &#x000df;-adrenergic stimulation in rats fed a high-fat diet</article-title><source>Korean J Nutr</source><year>1999</year><volume>32</volume><fpage>533</fpage><lpage>539</lpage></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Cornwell</surname><given-names>T</given-names></name><name><surname>Cohick</surname><given-names>W</given-names></name><name><surname>Raskin</surname><given-names>I</given-names></name><article-title>Dietary phytoestrogens and health</article-title><source>Phytochemistry</source><year>2004</year><volume>65</volume><fpage>995</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2004.03.005</pub-id><pub-id pub-id-type="pmid">15110680</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Suh</surname><given-names>HJ</given-names></name><article-title>Pharmacological effects of fermented red pepper</article-title><source>Phytother Res</source><year>2004</year><volume>18</volume><fpage>884</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1002/ptr.1490</pub-id><pub-id pub-id-type="pmid">15597334</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Im</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><article-title>Weight Reduction and Lipid Lowering Effects of Korean Traditional Soybean Fermented Products</article-title><source>J Korean Soc Food Sci Nutr</source><year>2006</year><volume>35</volume><fpage>1194</fpage><lpage>1199</lpage></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Choi</surname><given-names>U</given-names></name><name><surname>Lim</surname><given-names>D</given-names></name><name><surname>Lim</surname><given-names>M</given-names></name><article-title>Studies on the physicochemical characteristics of traditional Kochujang</article-title><source>Korean J Food Sic Technol</source><year>1996</year><volume>28</volume><fpage>157</fpage><lpage>161</lpage></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Jeong</surname><given-names>D</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><article-title>Studies on the physicochemical characteristics of Sunchang traditional Kochujang</article-title><source>Korean J Food Cult</source><year>2001</year><volume>16</volume><fpage>260</fpage><lpage>267</lpage></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Choi</surname><given-names>U</given-names></name><name><surname>Lim</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>E</given-names></name><article-title>Taste components of traditional Kochujang prepared with various raw materials</article-title><source>Korean J Food Sci Technol</source><year>1997</year><volume>29</volume><fpage>913</fpage><lpage>918</lpage></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Rhee</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>K</given-names></name><name><surname>Jung</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><article-title>Decreasing effects Kochujang on body weight and lipid levels of adipose tissues and serum in rats fed a high-fat diet</article-title><source>J Food Sci Nutr</source><year>2003</year><volume>32</volume><fpage>882</fpage><lpage>886</lpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Koo</surname><given-names>B</given-names></name><name><surname>Seong</surname><given-names>SH</given-names></name><name><surname>Kown</surname><given-names>DY</given-names></name><name><surname>Sohn</surname><given-names>HS</given-names></name><name><surname>Cha</surname><given-names>YS</given-names></name><article-title>Fermented Kochujang supplement shows anti-obesity effects by controlling lipid metabolism in C57BL/6J mice fed high fat diet</article-title><source>Food Sci Biotechnol</source><year>2008</year><volume>17</volume><fpage>336</fpage><lpage>342</lpage></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Choo</surname><given-names>J</given-names></name><article-title>Anti-obesity effects of Kochujang in rats fed on high fed diet</article-title><source>The Korean J Nutr</source><year>2000</year><volume>33</volume><fpage>787</fpage><lpage>793</lpage></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Back</surname><given-names>HI</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name><name><surname>Yang</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>MG</given-names></name><name><surname>Chae</surname><given-names>SW</given-names></name><name><surname>Cha</surname><given-names>YS</given-names></name><article-title>Effects of Chungkookjang supplementation on obesity and atherosclerotic indices in overweight/obese subjects: a 12-week, randomized, double-blind, placebo-controlled clinical trial</article-title><source>J Med Food</source><year>2011</year><volume>14</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1089/jmf.2010.1199</pub-id><pub-id pub-id-type="pmid">21434780</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Soh</surname><given-names>JR</given-names></name><name><surname>Shin</surname><given-names>DH</given-names></name><name><surname>Kwon</surname><given-names>DY</given-names></name><name><surname>Cha</surname><given-names>YS</given-names></name><article-title>Effect of Cheonggukjang supplementation upon hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, acyl-CoA oxidase and uncoupling protein 2 mRNA levels in C57BL/6J mice fed with high fat diet</article-title><source>Genes Nutr</source><year>2008</year><volume>2</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s12263-007-0066-x</pub-id><pub-id pub-id-type="pmid">18850232</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Ludy</surname><given-names>MJ</given-names></name><name><surname>Mattes</surname><given-names>RD</given-names></name><article-title>The effects of hedonically acceptable red pepper doses on thermogenesis and appetite</article-title><source>Physiol Behav</source><year>2011</year><volume>102</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2010.11.018</pub-id><pub-id pub-id-type="pmid">21093467</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Reinbach</surname><given-names>HC</given-names></name><name><surname>Smeets</surname><given-names>A</given-names></name><name><surname>Martinussen</surname><given-names>T</given-names></name><name><surname>Moller</surname><given-names>P</given-names></name><name><surname>Westerterp-Plantenga</surname><given-names>MS</given-names></name><article-title>Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance</article-title><source>Clin Nutr</source><year>2009</year><volume>28</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2009.01.010</pub-id><pub-id pub-id-type="pmid">19345452</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Yoshioka</surname><given-names>M</given-names></name><name><surname>St-Pierre</surname><given-names>S</given-names></name><name><surname>Drapeau</surname><given-names>V</given-names></name><name><surname>Dionne</surname><given-names>I</given-names></name><name><surname>Doucet</surname><given-names>E</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Tremblay</surname><given-names>A</given-names></name><article-title>Effects of red pepper on appetite and energy intake</article-title><source>Br J Nutr</source><year>1999</year><volume>82</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">10743483</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>IK</given-names></name><name><surname>Yoo</surname><given-names>KY</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>OK</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Shin</surname><given-names>HC</given-names></name><name><surname>Won</surname><given-names>MH</given-names></name><article-title>Immunohistochemical Changes in Orexigenic and Anorexigenic Neuropeptides in the Rat Hypothalamus after Capsaicin Administration</article-title><source>J Vet Med Sci</source><year>2009</year><volume>71</volume><fpage>1337</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1292/jvms.001337</pub-id><pub-id pub-id-type="pmid">19887740</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Udani</surname><given-names>J</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Madsen</surname><given-names>DC</given-names></name><article-title>Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract</article-title><source>Altern Med Rev</source><year>2004</year><volume>9</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">15005645</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Friedman</surname><given-names>JH</given-names></name><name><surname>Dubinsky</surname><given-names>R</given-names></name><article-title>The placebo effect</article-title><source>Neurology</source><year>2008</year><volume>71</volume><fpage>25</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000326599.25633.bb</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name><article-title>Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents</article-title><source>Clin Endocrinol (Oxf)</source><year>2011</year><volume>74</volume><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2010.03953.x</pub-id><pub-id pub-id-type="pmid">21138461</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Snitker</surname><given-names>S</given-names></name><name><surname>Fujishima</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>HQ</given-names></name><name><surname>Ott</surname><given-names>S</given-names></name><name><surname>Pi-Sunyer</surname><given-names>X</given-names></name><name><surname>Furuhata</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><article-title>Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>89</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">19056576</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>U</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Suh</surname><given-names>H</given-names></name><name><surname>Oh</surname><given-names>S</given-names></name><article-title>Weight reduction effect of extract of fermented red pepper on female college students</article-title><source>J Korean Soc Food Sci Nutr</source><year>2003</year><volume>32</volume><fpage>479</fpage><lpage>484</lpage></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Gwak</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Prak</surname><given-names>HW</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Hyun</surname><given-names>YJ</given-names></name><article-title>The effect of L-carnitine and isoflavone supplementation on weight reduction and visceral fat accumulation in overweight women.</article-title><source>Korean J Nutr</source><year>2007</year><volume>40</volume><fpage>9</fpage></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Oka</surname><given-names>J</given-names></name><name><surname>Tabata</surname><given-names>I</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>T</given-names></name><name><surname>Fuku</surname><given-names>N</given-names></name><name><surname>Ezaki</surname><given-names>J</given-names></name><name><surname>Sugiyama</surname><given-names>F</given-names></name><name><surname>Uchiyama</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Ishimi</surname><given-names>Y</given-names></name><article-title>Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial</article-title><source>J Bone Miner Res</source><year>2006</year><volume>21</volume><fpage>780</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1359/jbmr.060208</pub-id><pub-id pub-id-type="pmid">16734394</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Chae</surname><given-names>S</given-names></name><name><surname>Cha</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><article-title>Supplementation of Korean fermented soy paste doenjang reduces visceral fat in overweight subjects with mutant uncoupling protein-1 allele</article-title><source>Nutr Res</source><year>2012</year><volume>32</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2011.12.002</pub-id><pub-id pub-id-type="pmid">22260858</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>JA</given-names></name><name><surname>Tirupathi Pichiah</surname><given-names>PB</given-names></name><name><surname>Yu</surname><given-names>JJ</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Daily</surname><given-names>JW</given-names><suffix>3rd</suffix></name><name><surname>Cha</surname><given-names>YS</given-names></name><article-title>Anti-obesity effect of kimchi fermented with Weissella koreensis OK1-6 as starter in high-fat diet-induced obese C57BL/6J mice</article-title><source>J Appl Microbiol</source><year>2012</year><volume>113</volume><fpage>1507</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1111/jam.12017</pub-id><pub-id pub-id-type="pmid">22978326</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Oi</surname><given-names>Y</given-names></name><name><surname>Kawada</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Iwai</surname><given-names>K</given-names></name><article-title>Induction of capsaicin-hydrolyzing enzyme-activity in rat-liver by continuous oral-administration of capsaicin.</article-title><source>J Agric Food Chem</source><year>1992</year><volume>40</volume><fpage>467</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1021/jf00015a021</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>M</given-names></name><name><surname>Baek</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><article-title>The effect of Kimchi pill supplementation on plasma lipid concentration in healthy people</article-title><source>J Korean Soc Food Sci Nutr</source><year>2001</year><volume>30</volume><fpage>913</fpage><lpage>920</lpage></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Kwon</surname><given-names>DY</given-names></name><name><surname>Daily</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><article-title>Antidiabetic effects of fermented soybean products on type 2 diabetes</article-title><source>Nutr Res</source><year>2010</year><volume>30</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">20116654</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>MO</given-names></name><article-title>Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha</article-title><source>Mol Cell Endocrinol</source><year>2004</year><volume>220</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2004.03.011</pub-id><pub-id pub-id-type="pmid">15196699</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>HW</given-names></name><name><surname>Cha</surname><given-names>YS</given-names></name><article-title>Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet</article-title><source>J Med Food</source><year>2006</year><volume>9</volume><fpage>459</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1089/jmf.2006.9.459</pub-id><pub-id pub-id-type="pmid">17201630</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Jang KHK</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>NY</given-names></name><name><surname>Jin</surname><given-names>DR</given-names></name><article-title>Korea&#x02019;s health and Welfare trends</article-title><source>Seoul</source><year>2010</year><volume>128</volume><fpage>128</fpage></mixed-citation></ref></ref-list></back></article>